6c3fd2dd__Trials_Monthly___October_2013__Description
[NCI Designation] NCT01807182 [Disease Site] Melanoma [Description] 
Cellular Adoptive Immunotherapy Using Autologous Tumor-Infiltrating Lymphocytes Following Lymphodepletion with Cyclophosphamide and Fludarabine for Patients with Metastatic Melanoma
Seattle Cancer Care Alliance | Clinical Trials Monthly - October 2013
Description